i
Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers
-
February 14 2020
Source: Clin Infect Dis. 70(5):789-797
[PDF-335.48 KB]
Details:
-
Alternative Title:Clin Infect Dis
-
Personal Author:
-
Corporate Authors:
-
Description:Background.
Human immunodeficiency virus (HIV) viral suppression (VS) decreases morbidity, mortality, and transmission risk.
Methods.
The Patient-centered HIV Care Model integrated community-based pharmacists with HIV medical providers and required them to share patient clinical information, identify therapy-related problems, and develop therapy-related action plans.
Results.
The 765 enrolled participants were 43% non-Hispanic black, 73% male, with a median age of 48 years; 421 and 649 were included in the adherence and VS analyses, respectively. Overall, proportions adherent to therapy remained unchanged. However, VS improved a relative 15% (75% to 86%, P < .001). Higher PDC (adjusted odds ratio [AOR], 1.74 per 1-level increase in PDC category [95% confidence interval {CI}, 1.30–2.34]) and baseline VS (AOR, 7.69 [95% CI, 3.96–15.7]) were associated with postimplementation VS. Although non-Hispanic black persons (AOR, 0.29 [95% CI, .12–.62]) had lower odds of suppression, VS improved a relative 23% (63% to 78%, P < .001).
Conclusions.
Integrated care models between community-based pharmacists and primary medical providers may identify and address HIV therapy–related problems and improve VS among persons with HIV.
-
Subject:
-
Source:
-
Pubmed ID:30953062
-
Pubmed Central ID:PMC6821576
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
More +
Email
CDC-INFO
